These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25510486)

  • 1. Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway.
    Gmeiner WH; Jennings-Gee J; Stuart CH; Pardee TS
    Leuk Res; 2015 Feb; 39(2):229-35. PubMed ID: 25510486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
    Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy.
    Gajate C; Mollinedo F
    J Biol Chem; 2005 Mar; 280(12):11641-7. PubMed ID: 15659383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
    Gajate C; Mollinedo F
    Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid rafts and Fas/FasL pathway may involve in elaidic acid-induced apoptosis of human umbilical vein endothelial cells.
    Rao H; Ma LX; Xu TT; Li J; Deng ZY; Fan YW; Li HY
    J Agric Food Chem; 2014 Jan; 62(3):798-807. PubMed ID: 24364735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.
    Reis-Sobreiro M; Gajate C; Mollinedo F
    Oncogene; 2009 Sep; 28(36):3221-34. PubMed ID: 19561642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
    Mollinedo F; Gajate C
    Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid raft-mediated Fas/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications.
    Gajate C; Mollinedo F
    J Leukoc Biol; 2015 Nov; 98(5):739-59. PubMed ID: 26246489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts.
    Yun SH; Park ES; Shin SW; Ju MH; Han JY; Jeong JS; Kim SH; Stonik VA; Kwak JY; Park JI
    Oncotarget; 2015 Sep; 6(29):27596-612. PubMed ID: 26318294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway.
    Bénéteau M; Pizon M; Chaigne-Delalande B; Daburon S; Moreau P; De Giorgi F; Ichas F; Rebillard A; Dimanche-Boitrel MT; Taupin JL; Moreau JF; Legembre P
    Mol Cancer Res; 2008 Apr; 6(4):604-13. PubMed ID: 18403639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of Fas-FasL membrane microdomains during apoptosis in a reconstituted cell-cell junction.
    Zhang L; Kaizuka Y; Hanagata N
    Biochem Biophys Res Commun; 2012 Jun; 422(2):298-304. PubMed ID: 22580277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MS-275 sensitizes osteosarcoma cells to Fas ligand-induced cell death by increasing the localization of Fas in membrane lipid rafts.
    Rao-Bindal K; Zhou Z; Kleinerman ES
    Cell Death Dis; 2012 Aug; 3(8):e369. PubMed ID: 22875006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency.
    van Blitterswijk WJ; Klarenbeek JB; van der Luit AH; Alderliesten MC; van Lummel M; Verheij M
    Biochem J; 2009 Dec; 425(1):225-34. PubMed ID: 19824885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid rafts as major platforms for signaling regulation in cancer.
    Mollinedo F; Gajate C
    Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment.
    Legembre P; Daburon S; Moreau P; Ichas F; de Giorgi F; Moreau JF; Taupin JL
    Mol Cell Biol; 2005 Aug; 25(15):6811-20. PubMed ID: 16024813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.
    Muppidi JR; Siegel RM
    Nat Immunol; 2004 Feb; 5(2):182-9. PubMed ID: 14745445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissecting lipid raft facilitated cell signaling pathways in cancer.
    Patra SK
    Biochim Biophys Acta; 2008 Apr; 1785(2):182-206. PubMed ID: 18166162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
    Gajate C; Del Canto-Jañez E; Acuña AU; Amat-Guerri F; Geijo E; Santos-Beneit AM; Veldman RJ; Mollinedo F
    J Exp Med; 2004 Aug; 200(3):353-65. PubMed ID: 15289504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity.
    Cahuzac N; Baum W; Kirkin V; Conchonaud F; Wawrezinieck L; Marguet D; Janssen O; Zörnig M; Hueber AO
    Blood; 2006 Mar; 107(6):2384-91. PubMed ID: 16282344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rh2 induces ligand-independent Fas activation via lipid raft disruption.
    Yi JS; Choo HJ; Cho BR; Kim HM; Kim YN; Ham YM; Ko YG
    Biochem Biophys Res Commun; 2009 Jul; 385(2):154-9. PubMed ID: 19445898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.